IDEAYA Biosciences, Inc. (IDYA) Deep Dive Video

Name: IDEAYA Biosciences, Inc. (IDYA) Deep Dive Video | Flash
Uploaded: 2026-07-07T12:05:04.120Z
Description: IDEAYA Biosciences is evolving from cash-burning clinical biotech to late-stage precision oncology launch story, with darovasertib’s H2 2026 NDA filing and a $1.30 billion cash war chest creating asymmetric upside if uveal melanoma execution stays on track.

IDEAYA Biosciences, Inc. (IDYA) video thumbnail

Summary

IDEAYA Biosciences is evolving from cash-burning clinical biotech to late-stage precision oncology launch story, with darovasertib’s H2 2026 NDA filing and a $1.30 billion cash war chest creating asymmetric upside if uveal melanoma execution stays on track.

View IDYA stock page · Read the IDYA research report

Loading the video player…

Loading Flash…